Clinical trial
Safety of Ticagrelor Plus Warfarin Versus Clopidogrel+Aspirin+Warfarin in Patients With Persistent or Permanent Atrial Fibrillation and Undergoing PCI-S: A Randomized, Open, Controlled, Parallel Group, Multi-center Trial
NCT02206815 is registered in ClinicalTrials.gov with Genshan Ma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Ticagrelor Plus Warfarin Versus Clopidogrel+Aspirin+Warfarin in Patients With Persistent or Permanent Atrial Fibrillation and Undergoing PCI-S: A Randomized, Open, Controlled, Parallel Group, Multi-center Trial
- Lead sponsor
- Genshan Ma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 19, 2014
- Completion date
- February 20, 2019
- Enrollment
- 296 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.